Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Beyond deviancy-training: Deviant adolescent friendships and long-term social development.

Allen JP, Narr RK, Loeb EL, Davis AA.

Dev Psychopathol. 2019 Sep 9:1-10. doi: 10.1017/S095457941900083X. [Epub ahead of print]

PMID:
31496449
2.

Emerging Role of Genomics and Cell-Free DNA in Breast Cancer.

Gerratana L, Davis AA, Shah AN, Lin C, Corvaja C, Cristofanilli M.

Curr Treat Options Oncol. 2019 Jun 29;20(8):68. doi: 10.1007/s11864-019-0667-9. Review.

PMID:
31256282
3.

The effect of administration of intravenous intralipid on pregnancy outcomes in women with implantation failure after IVF/ICSI with non-donor oocytes: A randomised controlled trial.

Singh N, Davis AA, Kumar S, Kriplani A.

Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:45-51. doi: 10.1016/j.ejogrb.2019.06.007. Epub 2019 Jun 13.

PMID:
31228675
4.

RASopathy in Patients With Isolated Sagittal Synostosis.

Davis AA, Zuccoli G, Haredy MM, Losee J, Pollack IF, Madan-Khetarpal S, Goldstein JA, Nischal KK.

Glob Pediatr Health. 2019 May 12;6:2333794X19846774. doi: 10.1177/2333794X19846774. eCollection 2019.

5.

The Incidence of Chiari Malformations in Patients with Isolated Sagittal Synostosis.

Davis AA, Zuccoli G, Haredy MM, Runkel L, Losee J, Pollack IF, Tamber MS, Tyler-Kabara E, Goldstein JA, Nischal KK.

Plast Reconstr Surg Glob Open. 2019 Feb 12;7(2):e2090. doi: 10.1097/GOX.0000000000002090. eCollection 2019 Feb.

6.

Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.

Chae YK, Davis AA, Agte S, Pan A, Simon NI, Iams WT, Cruz MR, Tamragouri K, Rhee K, Mohindra N, Villaflor V, Park W, Lopes G, Giles FJ.

Oncologist. 2019 Jun;24(6):820-828. doi: 10.1634/theoncologist.2018-0433. Epub 2019 Mar 13.

PMID:
30867242
7.

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.

Cristofanilli M, Pierga JY, Reuben J, Rademaker A, Davis AA, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Giuliano M, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Cabel L, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Generali D, Cappelletti MR, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Darrigues L, Reis-Filho JS, Gerratana L, Michiels S, Bidard FC, Pantel K.

Crit Rev Oncol Hematol. 2019 Feb;134:39-45. doi: 10.1016/j.critrevonc.2018.12.004. Epub 2018 Dec 19. Review.

PMID:
30771872
8.

Chronic uterine inversion with malignancy mimicking carcinoma cervix.

Girish B, Davis AA.

BMJ Case Rep. 2019 Feb 1;12(2). pii: bcr-2018-225541. doi: 10.1136/bcr-2018-225541.

PMID:
30709891
9.

A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson's Disease.

Younce JR, Davis AA, Black KJ.

J Parkinsons Dis. 2019;9(1):63-71. doi: 10.3233/JPD-181448.

10.

Combined bead-based multiplex detection of RNA and protein biomarkers: Implications for understanding the time course of skeletal muscle injury and repair.

Gary MA, Tanner EA, Davis AA, McFarlin BK.

Methods. 2019 Apr 1;158:92-96. doi: 10.1016/j.ymeth.2018.11.012. Epub 2018 Nov 22.

PMID:
30472250
11.

Combining single molecule counting with bead-based multiplexing to quantify biological inflammation time course following skeletal muscle injury.

Tanner EA, Gary MA, Davis AA, McFarlin BK.

Methods. 2019 Apr 1;158:77-80. doi: 10.1016/j.ymeth.2018.11.013. Epub 2018 Nov 22.

PMID:
30472249
12.

Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.

Chae YK, Davis AA, Raparia K, Agte S, Pan A, Mohindra N, Villaflor V, Giles F.

Clin Lung Cancer. 2019 Mar;20(2):88-96.e6. doi: 10.1016/j.cllc.2018.09.008. Epub 2018 Sep 25.

PMID:
30425022
13.

Complexity of Delivering Precision Medicine: Opportunities and Challenges.

Davis AA, McKee AE, Kibbe WA, Villaflor VM.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:998-1007. doi: 10.1200/EDBK_200279. Review.

PMID:
30231318
14.

Intercellular Spread of Protein Aggregates in Neurodegenerative Disease.

Davis AA, Leyns CEG, Holtzman DM.

Annu Rev Cell Dev Biol. 2018 Oct 6;34:545-568. doi: 10.1146/annurev-cellbio-100617-062636. Epub 2018 Jul 25. Review.

15.

Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease.

Ibanez L, Dube U, Davis AA, Fernandez MV, Budde J, Cooper B, Diez-Fairen M, Ortega-Cubero S, Pastor P, Perlmutter JS, Cruchaga C, Benitez BA.

Front Neurosci. 2018 Apr 10;12:230. doi: 10.3389/fnins.2018.00230. eCollection 2018.

16.

Cerebrovascular Events After Continuous-Flow Left Ventricular Assist Devices.

Tahsili-Fahadan P, Curfman DR, Davis AA, Yahyavi-Firouz-Abadi N, Rivera-Lara L, Nassif ME, LaRue SJ, Ewald GA, Zazulia AR.

Neurocrit Care. 2018 Oct;29(2):225-232. doi: 10.1007/s12028-018-0531-y.

PMID:
29637518
17.

A womb like a broken heart.

Davis AA.

BMJ Case Rep. 2018 Feb 22;2018. pii: bcr-2017-222075. doi: 10.1136/bcr-2017-222075.

PMID:
29472419
18.

Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer.

Chae YK, Choi WM, Bae WH, Anker J, Davis AA, Agte S, Iams WT, Cruz M, Matsangou M, Giles FJ.

Sci Rep. 2018 Jan 18;8(1):1023. doi: 10.1038/s41598-018-19454-3.

19.

Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support.

Chae YK, Pan AP, Davis AA, Patel SP, Carneiro BA, Kurzrock R, Giles FJ.

Mol Cancer Ther. 2017 Dec;16(12):2645-2655. doi: 10.1158/1535-7163.MCT-17-0597. Review.

20.

Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.

Ibanez L, Dube U, Saef B, Budde J, Black K, Medvedeva A, Del-Aguila JL, Davis AA, Perlmutter JS, Harari O, Benitez BA, Cruchaga C.

BMC Neurol. 2017 Nov 15;17(1):198. doi: 10.1186/s12883-017-0978-z.

21.

TMEM230 in Parkinson's disease.

Ibanez L, Dube U, Budde J, Black K, Medvedeva A, Davis AA, Perlmutter JS, Benitez BA, Cruchaga C.

Neurobiol Aging. 2017 Aug;56:212.e1-212.e3. doi: 10.1016/j.neurobiolaging.2017.03.014. Epub 2017 Mar 16.

22.

Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer.

Chae YK, Davis AA, Jain S, Santa-Maria C, Flaum L, Beaubier N, Platanias LC, Gradishar W, Giles FJ, Cristofanilli M.

Mol Cancer Ther. 2017 Jul;16(7):1412-1420. doi: 10.1158/1535-7163.MCT-17-0061. Epub 2017 Apr 26.

23.

Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins.

Huynh TV, Davis AA, Ulrich JD, Holtzman DM.

J Lipid Res. 2017 May;58(5):824-836. doi: 10.1194/jlr.R075481. Epub 2017 Feb 27. Review. Erratum in: J Lipid Res. 2018 Aug;59(8):1546.

24.

Parkinson disease and cognitive impairment: Five new things.

Davis AA, Racette B.

Neurol Clin Pract. 2016 Oct;6(5):452-458. Review.

25.

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.

Chae YK, Davis AA, Carneiro BA, Chandra S, Mohindra N, Kalyan A, Kaplan J, Matsangou M, Pai S, Costa R, Jovanovic B, Cristofanilli M, Platanias LC, Giles FJ.

Oncotarget. 2016 Oct 4;7(40):65364-65373. doi: 10.18632/oncotarget.11692.

26.

Recent Advances and Future Strategies for Immune-Checkpoint Inhibition in Small-Cell Lung Cancer.

Chae YK, Pan A, Davis AA, Mohindra N, Matsangou M, Villaflor V, Giles F.

Clin Lung Cancer. 2017 Mar;18(2):132-140. doi: 10.1016/j.cllc.2016.07.004. Epub 2016 Jul 9. Review.

PMID:
27520630
27.

Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?

Chae YK, Pan A, Davis AA, Raparia K, Mohindra NA, Matsangou M, Giles FJ.

Clin Lung Cancer. 2016 Sep;17(5):350-361. doi: 10.1016/j.cllc.2016.03.011. Epub 2016 Apr 6. Review.

PMID:
27137346
28.

Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.

Benitez BA, Davis AA, Jin SC, Ibanez L, Ortega-Cubero S, Pastor P, Choi J, Cooper B, Perlmutter JS, Cruchaga C.

Mol Neurodegener. 2016 Apr 19;11:29. doi: 10.1186/s13024-016-0097-0.

29.

Immunotherapy for cancer in the central nervous system: Current and future directions.

Binder DC, Davis AA, Wainwright DA.

Oncoimmunology. 2015 Sep 11;5(2):e1082027. eCollection 2016 Feb. Review.

30.

Community Attitudes and Practices of Urban Residents Regarding Predation by Pet Cats on Wildlife: An International Comparison.

Hall CM, Adams NA, Bradley JS, Bryant KA, Davis AA, Dickman CR, Fujita T, Kobayashi S, Lepczyk CA, McBride EA, Pollock KH, Styles IM, van Heezik Y, Wang F, Calver MC.

PLoS One. 2016 Apr 6;11(4):e0151962. doi: 10.1371/journal.pone.0151962. eCollection 2016.

31.

Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.

Davis AA, Andruska KM, Benitez BA, Racette BA, Perlmutter JS, Cruchaga C.

Neurobiol Aging. 2016 Jan;37:209.e1-209.e7. doi: 10.1016/j.neurobiolaging.2015.09.014. Epub 2015 Sep 30.

32.

Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling.

Chae YK, Chung SY, Davis AA, Carneiro BA, Chandra S, Kaplan J, Kalyan A, Giles FJ.

Oncotarget. 2015 Nov 10;6(35):37117-34. doi: 10.18632/oncotarget.5076. Review.

33.

Severe anorexia nervosa in a 20-year-old male with pericardial effusion and cortical atrophy.

Shapiro M, Davis AA, Nguyen ML.

Int J Psychiatry Med. 2014;48(2):95-102. doi: 10.2190/PM.48.2.b.

PMID:
25377150
34.

A case study of anorexia nervosa driven by religious sacrifice.

Davis AA, Nguyen M.

Case Rep Psychiatry. 2014;2014:512764. doi: 10.1155/2014/512764. Epub 2014 Jul 6.

35.

Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2.

Jackson SA, Davis AA, Li J, Yi N, McCormick SR, Grant C, Fallen T, Crawford B, Loranger K, Litton J, Arun B, Vande Wydeven K, Sidani A, Farmer K, Sanders M, Hoskins K, Nussbaum R, Esserman L, Garber JE, Kaklamani VG; Northwestern Cancer Genetics Group.

Cancer. 2014 May 15;120(10):1557-64. doi: 10.1002/cncr.28577. Epub 2014 Feb 12.

36.

Optoporation and genetic manipulation of cells using femtosecond laser pulses.

Davis AA, Farrar MJ, Nishimura N, Jin MM, Schaffer CB.

Biophys J. 2013 Aug 20;105(4):862-71. doi: 10.1016/j.bpj.2013.07.012.

37.

Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models.

Digby GJ, Noetzel MJ, Bubser M, Utley TJ, Walker AG, Byun NE, Lebois EP, Xiang Z, Sheffler DJ, Cho HP, Davis AA, Nemirovsky NE, Mennenga SE, Camp BW, Bimonte-Nelson HA, Bode J, Italiano K, Morrison R, Daniels JS, Niswender CM, Olive MF, Lindsley CW, Jones CK, Conn PJ.

J Neurosci. 2012 Jun 20;32(25):8532-44. doi: 10.1523/JNEUROSCI.0337-12.2012.

38.

Optimized half-wave voltage and insertion loss in a strip-loaded waveguide electro-optic polymer modulator.

Davis AA, Yaney PP, Grote JG.

Appl Opt. 2012 May 20;51(15):2917-24. doi: 10.1364/AO.51.002917.

PMID:
22614594
39.

Metabolic syndrome and triple-negative breast cancer: a new paradigm.

Davis AA, Kaklamani VG.

Int J Breast Cancer. 2012;2012:809291. doi: 10.1155/2012/809291. Epub 2011 Oct 15.

40.

Prescribing information therapy: opportunity for improved physician-patient communication and patient health literacy.

Chesser AK, Woods NC, Davis AA, Bowers CJ.

J Prim Care Community Health. 2012 Jan 1;3(1):6-10. doi: 10.1177/2150131911414712. Epub 2011 Aug 5.

PMID:
23804848
41.

Age differences in daily predictors of forgetting to take medication: the importance of context and cognition.

Neupert SD, Patterson TR, Davis AA, Allaire JC.

Exp Aging Res. 2011 Jul;37(4):435-48. doi: 10.1080/0361073X.2011.590757.

PMID:
21800973
42.

Director configuration transitions of polyelectrolyte coated liquid-crystal droplets.

Zou J, Bera T, Davis AA, Liang W, Fang J.

J Phys Chem B. 2011 Jul 28;115(29):8970-4. doi: 10.1021/jp201909m. Epub 2011 Jun 27.

PMID:
21667976
43.

Differential effects of allosteric M(1) muscarinic acetylcholine receptor agonists on receptor activation, arrestin 3 recruitment, and receptor downregulation.

Davis AA, Heilman CJ, Brady AE, Miller NR, Fuerstenau-Sharp M, Hanson BJ, Lindsley CW, Conn PJ, Lah JJ, Levey AI.

ACS Chem Neurosci. 2010 Aug 18;1(8):542-551.

44.

Paraphilias in adult psychiatric inpatients.

Marsh PJ, Odlaug BL, Thomarios N, Davis AA, Buchanan SN, Meyer CS, Grant JE.

Ann Clin Psychiatry. 2010 May;22(2):129-34.

PMID:
20445840
45.

Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo.

Davis AA, Fritz JJ, Wess J, Lah JJ, Levey AI.

J Neurosci. 2010 Mar 24;30(12):4190-6. doi: 10.1523/JNEUROSCI.6393-09.2010.

46.

A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors.

Jeon J, Dencker D, Wörtwein G, Woldbye DP, Cui Y, Davis AA, Levey AI, Schütz G, Sager TN, Mørk A, Li C, Deng CX, Fink-Jensen A, Wess J.

J Neurosci. 2010 Feb 10;30(6):2396-405. doi: 10.1523/JNEUROSCI.3843-09.2010.

47.

Delayed presentation of tetraparesis following posterior thoracolumbar spinal fusion and instrumentation for adolescent idiopathic scoliosis.

Dapunt UA, Mok JM, Sharkey MS, Davis AA, Foster-Barber A, Diab M.

Spine (Phila Pa 1976). 2009 Dec 1;34(25):E936-41. doi: 10.1097/BRS.0b013e3181b2e04f.

PMID:
19940725
48.

A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.

Shirey JK, Brady AE, Jones PJ, Davis AA, Bridges TM, Kennedy JP, Jadhav SB, Menon UN, Xiang Z, Watson ML, Christian EP, Doherty JJ, Quirk MC, Snyder DH, Lah JJ, Levey AI, Nicolle MM, Lindsley CW, Conn PJ.

J Neurosci. 2009 Nov 11;29(45):14271-86. doi: 10.1523/JNEUROSCI.3930-09.2009.

49.

Legal consequences of kleptomania.

Grant JE, Odlaug BL, Davis AA, Kim SW.

Psychiatr Q. 2009 Dec;80(4):251-9. doi: 10.1007/s11126-009-9112-8.

PMID:
19813092
50.

Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.

Jones CK, Brady AE, Davis AA, Xiang Z, Bubser M, Tantawy MN, Kane AS, Bridges TM, Kennedy JP, Bradley SR, Peterson TE, Ansari MS, Baldwin RM, Kessler RM, Deutch AY, Lah JJ, Levey AI, Lindsley CW, Conn PJ.

J Neurosci. 2008 Oct 8;28(41):10422-33. doi: 10.1523/JNEUROSCI.1850-08.2008.

Supplemental Content

Loading ...
Support Center